Your browser doesn't support javascript.
loading
Thyroid Eye Disease: Epidemiology, Natural History, and Risk Factors.
Bartalena, Luigi; Gallo, Daniela; Tanda, Maria Laura; Kahaly, George J.
Afiliación
  • Bartalena L; School of Medicine.
  • Gallo D; Department of Medicine and Surgery, University of Insubria, Varese, Italy.
  • Tanda ML; Department of Medicine and Surgery, University of Insubria, Varese, Italy.
  • Kahaly GJ; Department of Medicine I, Johannes Gutenberg University, Mainz, Germany.
Ophthalmic Plast Reconstr Surg ; 39(6S): S2-S8, 2023 12 01.
Article en En | MEDLINE | ID: mdl-38054980
ABSTRACT

BACKGROUND:

Thyroid eye disease (TED) is an autoimmune disorder of the orbit and the most frequent extrathyroidal manifestation of Graves' disease but it may rarely occur in euthyroid/hypothyroid patients with chronic autoimmune thyroiditis. EPIDEMIOLOGY TED is a relatively infrequent disorder, particularly in its severe forms. Men tend to have more severe TED at an older age. The prevalence of TED is lower than in the past among patients with recent onset Graves' hyperthyroidism, and moderate-to-severe forms requiring aggressive treatments are no more than 5% to 6% of all cases. NATURAL HISTORY After an initial inflammatory (active) phase and a plateau phase, TED stabilizes and eventually inactivates (inactive or burnt-out phase) after an estimated period of 18-24 months. Minimal-to-mild TED often remits spontaneously, but complete restitutio ad integrum almost never occurs when TED is more than mild. RISK FACTORS Several risk factors contribute to its development on a yet undefined genetic background. Cigarette smoking is the most important of them, but thyroid dysfunction (both hyper- and hypothyroidism), radioactive iodine therapy (if not accompanied by low-dose steroid prophylaxis), elevated thyrotropin receptor antibodies, and, probably, hypercholesterolemia represent relevant modifiable risk factors. Early diagnosis, control and removal of modifiable risk factors, and early treatment of mild forms of GO (local treatment and selenium) may effectively limit the risk of progression to more severe forms.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Enfermedad de Graves / Oftalmopatía de Graves Límite: Humans / Male Idioma: En Revista: Ophthalmic Plast Reconstr Surg Asunto de la revista: OFTALMOLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Enfermedad de Graves / Oftalmopatía de Graves Límite: Humans / Male Idioma: En Revista: Ophthalmic Plast Reconstr Surg Asunto de la revista: OFTALMOLOGIA Año: 2023 Tipo del documento: Article